ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA
· Real-Time Price · USD
3.37
-0.19 (-5.34%)
At close: Jun 05, 2025, 3:59 PM
3.24
-3.71%
After-hours: Jun 05, 2025, 07:50 PM EDT
-5.34% (1D)
| Bid | 2.54 |
| Market Cap | 2.48M |
| Revenue (ttm) | 211.6K |
| Net Income (ttm) | -9.77M |
| EPS (ttm) | 390.78 |
| PE Ratio (ttm) | 0.01 |
| Forward PE | -0.36 |
| Analyst | Buy |
| Ask | 3.39 |
| Volume | 16,722 |
| Avg. Volume (20D) | 171,066 |
| Open | 3.72 |
| Previous Close | 3.56 |
| Day's Range | 3.28 - 3.72 |
| 52-Week Range | 2.90 - 287.00 |
| Beta | -0.22 |
About NDRA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NDRA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NDRA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
-14.18%
ENDRA Life Sciences shares are trading lower. The ...
Unlock content with
Pro Subscription
7 months ago
+89.02%
ENDRA Life Sciences shares are trading higher after the company announced the activation of a post market clinical study of the TAEUS liver system.
